Within 10 years, SATVI has become a world leader in TB vaccine clinical research
SATVI conducts TB vaccine clinical research within an academic context, producing over 70 publications in high impact international peer reviewed journals since 2006
SATVI develops the capacity of Masters, PhD and Doctoral students, producing young scientists committed to TB research
SATVI works extensively with other partners, and has received major funding from Aeras and the Bill & Melinda Gates Foundation
A significant number of SATVI’s projects are funded through investigator-driven grants, including the NIH, EDCTP and the Bill & Melinda Gates Foundation
Community participation and support has been critical to our research
SATVI has been actively involved in TB vaccine advocacy
